Key facts today
DexCom, Inc. is partnering with American Diversified Holdings on the GlucoGuard project, aimed at Continuous Glucose Monitoring (CGM) technology, backed by up to $5 million in funding.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
27.35 MXN
12.01 B MXN
84.09 B MXN
386.73 M
About DexCom, Inc.
Sector
Industry
CEO
Jacob S. Leach
Website
Headquarters
San Diego
Founded
1999
ISIN
US2521311074
FIGI
BBG00F5P1254
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Related stocks
$DXCM – Bearish Setup Developing📉 NASDAQ:DXCM – Bearish Setup Developing
DexCom ( NASDAQ:DXCM ) took a major hit today after cutting revenue guidance by 12% to $1.2B.
A 30% drop in user base triggered an 11% selloff, confirming structural weakness.
Options flow shows strong bearish positioning:
🔻 3,000-lot block of Nov $65 pu
DXCM DexCom Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DXCM DexCom prior to the earnings report this week,
I would consider purchasing the 90usd strike price Calls with
an expiration date of 2025-2-21,
for a premium of approximately $1.65.
If these options prove to be profitable prior to the earnings
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
DXCM5195221
DexCom, Inc. 0.25% 15-NOV-2025Yield to maturity
—
Maturity date
Nov 15, 2025
DXCM5813816
DexCom, Inc. 0.375% 15-MAY-2028Yield to maturity
—
Maturity date
May 15, 2028
See all DXCM bonds
Frequently Asked Questions
The current price of DXCM is 1,217.74 MXN — it has decreased by −0.19% in the past 24 hours. Watch DexCom, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange DexCom, Inc. stocks are traded under the ticker DXCM.
DXCM stock has fallen by −1.48% compared to the previous week, the month change is a −13.76% fall, over the last year DexCom, Inc. has showed a −9.80% decrease.
We've gathered analysts' opinions on DexCom, Inc. future price: according to them, DXCM price has a max estimate of 2,220.17 MXN and a min estimate of 1,572.62 MXN. Watch DXCM chart and read a more detailed DexCom, Inc. stock forecast: see what analysts think of DexCom, Inc. and suggest that you do with its stocks.
DXCM reached its all-time high on Nov 19, 2021 with the price of 3,366.38 MXN, and its all-time low was 212.77 MXN and was reached on Oct 25, 2017. View more price dynamics on DXCM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DXCM stock is 0.19% volatile and has beta coefficient of 1.25. Track DexCom, Inc. stock price on the chart and check out the list of the most volatile stocks — is DexCom, Inc. there?
Today DexCom, Inc. has the market capitalization of 473.53 B, it has decreased by −1.29% over the last week.
Yes, you can track DexCom, Inc. financials in yearly and quarterly reports right on TradingView.
DexCom, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
DXCM earnings for the last quarter are 9.00 MXN per share, whereas the estimation was 8.32 MXN resulting in a 8.21% surprise. The estimated earnings for the next quarter are 10.44 MXN per share. See more details about DexCom, Inc. earnings.
DexCom, Inc. revenue for the last quarter amounts to 21.71 B MXN, despite the estimated figure of 21.10 B MXN. In the next quarter, revenue is expected to reach 21.62 B MXN.
DXCM net income for the last quarter is 3.37 B MXN, while the quarter before that showed 2.16 B MXN of net income which accounts for 56.19% change. Track more DexCom, Inc. financial stats to get the full picture.
No, DXCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 17, 2025, the company has 10.3 K employees. See our rating of the largest employees — is DexCom, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DexCom, Inc. EBITDA is 17.32 B MXN, and current EBITDA margin is 20.28%. See more stats in DexCom, Inc. financial statements.
Like other stocks, DXCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DexCom, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DexCom, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DexCom, Inc. stock shows the strong sell signal. See more of DexCom, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.